Skip to main content
Home

Primary Menu

  • OUR STRATEGY
    • WHAT SETS US APART
    • OUR HISTORY
    • OUR LEADERSHIP
    • FAQ
  • OUR IMPACT
    • WHAT WE SUPPORT
    • CURRENT PROJECTS
    • TIMELINE
  • GET INVOLVED
    • WAYS TO DONATE
    • BECOME A SPONSOR
    • LEGACY PLANNING
    • FUNDRAISE
    • CORPORATE PARTNERS
  • FOR SCIENTISTS
    • AWARD PROGRAMS
    • APPLICATION GUIDELINES
    • GENERATIONS OF INNOVATORS
    • SELECTION COMMITTEES
    • ACCELERATING CANCER CURES
    • FAQ
  • NEWS
  • BROADWAY TICKETS
  • burger-menu
Search
search-button-x

Donate

  • DONATE

Damon Runyon News

View New Articles By

News

Honors and Awards September 20, 2016
The Importance of Young Scientists in Cancer Research

Lorraine Egan, President & Chief Executive Officer, Damon Runyon Cancer Research Foundation

A recent article in Nature, “The Unsung Heroes of CRISPR,” highlights the special role of young scientists in research breakthroughs.  They are “unsung,” because they rarely get the credit they deserve for being important drivers of innovation in research.  But they are crucial to progress against cancer and other biomedical research.

It made me think of Lin Manuel Miranda, the celebrated creator of Hamilton, who won his first Tony in 2008, when he was 28.  He is a classic example of a young person breaking the mold.  History is replete with stories of bold innovation by young minds.  Take Steve Jobs and Bill Gates to name two other contemporary examples.  The same is true in biomedical research.  In fact, the majority of Nobel Prizes in science have gone to individuals who made their prize-winning discovery before they were 40.

Read More
Honors and Awards September 14, 2016
Board Member Bill Kaelin Wins Prestigious Lasker Award

Yung S. Lie, PhD, Deputy Director and Chief Scientific Officer, Damon Runyon Cancer Research Foundation

Public support for basic scientific research is essential, as it can help insure that brilliant young people continue to enter the sciences and dedicate their careers to cancer research. It can also insure that there will always be another Bill Kaelin in the pipeline.

Bill is a trailblazing physician-scientist at the Dana-Farber Cancer Institute, a member of our Board of Directors, and a winner of the 2016 Albert Lasker Basic Medical Research Award for his work on the pathway by which cells sense and adapt to changes in oxygen levels. The Boston Globe lauded the significance of Bill’s contributions to science and observed that, “This work on oxygen sensing has led to the development of potential drugs for heart attack, stroke, and kidney cancer, as well as possible treatments for anemia and retinopathy of prematurity, a condition that can blind premature infants.”

Read More
Honors and Awards September 12, 2016
Welcome to the Damon Runyon Blog

Lorraine Egan, President & Chief Executive Officer, Damon Runyon Cancer Research Foundation

Read More

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23

ABOUT

Annual Reports + Report Cards
Financial Overview
Our Team

CONNECT

1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006

Damon Runyon Cancer Research Foundation on Facebook Damon Runyon Cancer Research Foundation on LinkedIn Damon Runyon Cancer Research Foundation on BlueSky Damon Runyon Cancer Research Foundation on Instagram Damon Runyon Cancer Research Foundation on Youtube

    

© COPYRIGHT DAMON RUNYON. ALL RIGHTS RESERVED

PRIVACY POLICY